Luo, Xiu
Li, Yi
Li, Heping
Wang, Liugen
Zeng, Jing
Song, Yunyun
Zeng, Xi
Funding for this research was provided by:
Henan Provincial Department of Science and Technology Key R&D Special Project
the NHC Key Laboratory of Prevention and Treatment of Cerebrovascular Disease
Medical technologies R & D Program of Henan province
Article History
Received: 5 August 2025
Accepted: 30 December 2025
First Online: 19 January 2026
Declarations
:
: The authors declare no competing interests.
: The study protocol was approved by the Ethics Committee of the First Affiliated Hospital of Zhengzhou University (2024-KY-0579-002).In addition, the trial has been registered on June 11, 2024 at ClinicalTrials.gov (NCT06464835) and was conducted in accordance with Good Clinical Practice and the regulatory standards of the Declaration of Helsinki.Participants gave informed consent to participate in the study before taking part.